Market Sentiment: Overall investor optimism or pessimism regarding the pharmaceutical industry and the specific company.

Financial Performance: Revenue, earnings, and profitability trends significantly impact investor confidence.

Drug Pipeline: The progress and potential of new drug candidates in development influence future growth expectations.

Regulatory Approvals: FDA decisions on drug approvals directly affect revenue potential and market value.

Competition: The presence and success of competing products can impact market share and pricing power.

Patent Protection: Exclusivity rights afforded by patents are crucial for maintaining profitability and fending off competition.

Economic Conditions: Macroeconomic factors like interest rates and inflation can influence investment decisions.

Company News: Announcements of mergers, acquisitions, or partnerships can trigger price fluctuations.

Analyst Ratings: Recommendations from financial analysts can sway investor sentiment and trading activity.

Industry Trends: Emerging trends in healthcare and pharmaceuticals affect the long-term outlook for the company.